| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Jun 23, 2025 | Axsome Therapeutics, Inc. | General Counsel | Sell | 5.0 | -13,514 | -100.00% | ✓ | $1.4M |
| Jun 16, 2025 | Jun 18, 2025 | Axsome Therapeutics, Inc. | General Counsel | Sell | 5.0 | -22,500 | -100.00% | ✓ | $2.3M |